Skip to search formSkip to main contentSkip to account menu

YM 14673

Known as: YM-14673 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1994
Highly Cited
1994
We used a new injury device that produces consistent spinal cord contusion injuries (T8) in rats to compare the behavioral and… 
1993
1993
A reproducible spinal cord injury model was used to compare the efficacy of three compounds previously shown to improve… 
1992
1992
Effects of a new thyrotropin-releasing hormone (TRH) analog, N alpha-[[(S)-4-oxo-2-azetidinyl]carbonyl]L-histidyl-L-prolinamide… 
1989
1989
The influence of YM-14673 (N alpha-[[(S)-4-oxo-2-azetidinyl]-carbonyl]-L-histidyl-L-prolinamide dihydrate), a new thyrotropin… 
1989
1989
We observed the effects of a new thyrotropin-releasing hormone derivative, YM-14673 (N alpha-[[(S)-4-oxo-2-azetidinyl]carbonyl]-L… 
1989
1989
Effects of YM-14673, a new thyrotropin-releasing hormone (TRH) analogue, on neurological deficits were observed in comparison… 
1988
1988
SummaryEffects of a new TRH analogue, YM-14673 (Nα-[[(S)-4-oxo-2-azetidinyl carbonyl]-l-histidyl-L-prolinamide dihydrate) on…